SCHEMBL5352146

SCHEMBL5352146

CC[Si](CC)(CC)OC(C1CCC(NS(=O)(=O)Cc2ccccc2)CC1)(C(F)(F)F)C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.43
ADRA1D P25100 1/20 0.43
ADRA1A P35348 1/20 0.43
ADRA1B P35368 1/20 0.43
LIPE Q05469 2/20 0.38
JAK2 O60674 1/20 0.37
JAK1 P23458 1/20 0.37
TYK2 P29597 1/20 0.37
HPGD P15428 3/20 0.36
ALDH1A1 P00352 2/20 0.36
F2R P25116 1/20 0.36
SUV39H2 Q9H5I1 2/20 0.35
NR1H2 P55055 1/20 0.35
STS P08842 1/20 0.34
RORC P51449 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
MMP1 P03956 1/20 0.33
MMP2 P08253 1/20 0.33
MMP9 P14780 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5354218 0.84 HTR1A (0.44) DRD2ADRA1DADRA1AADRA1BALDH1A1
SCHEMBL5358815 0.84 HTR1A (0.44) DRD2ADRA1DADRA1AADRA1BALDH1A1
SCHEMBL5348999 0.81 ACHE (0.44)
SCHEMBL5347919 0.81 ACHE (0.44)
SCHEMBL5360159 0.78 RORC (0.40) HPGDRORCUSP2HSD17B10
SCHEMBL5352716 0.77 DRD2 (0.43) DRD2ADRA1DADRA1AADRA1BLIPE
SCHEMBL4171714 0.75 CA1 (0.55) DRD2ADRA1DADRA1AADRA1BJAK2
SCHEMBL4603405 0.71 DRD2 (0.49) DRD2ADRA1DADRA1AADRA1BJAK2
SCHEMBL10153507 0.69 F2 (0.48) DRD2ADRA1DADRA1AADRA1BJAK2
SCHEMBL989727 0.68 HSP90AA1 (0.50) DRD2ADRA1DADRA1AADRA1BHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7253282-B2 Hexafluoroisopropanol substituted cyclohexane derivatives HOFFMAN-LA ROCHE INC. (US) 2007-08-07 US disclosed
US-20060135601-A1 Novel hexafluoroisopropanol substituted cyclohexane derivatives HOFFMANN-LA ROCHE INC. 2006-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135601-A1 Novel hexafluoroisopropanol substituted cyclohexane derivatives NR1H3, NR1H2, NR1I2 DRD2 1173/4885ADRA1D 56/4885ADRA1A 40/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.